Ruxolitinib Efficacy and Safety in Patients With HU Resistant or Intolerant Polycythemia Vera vs Best Available Therapy.
- Status
- COMPLETED
- Phase
- PHASE3
Clinical Trials Related to Polycythemia Vera
Related studies linked through entity extraction aliases.
Safety and Efficacy of Momelotinib in Subjects With Polycythemia Vera or Essential Thrombocythemia
- Status
- TERMINATED
- Phase
- PHASE2
A Phase 2 Study of RO7490677 In Participants With Myelofibrosis
- Status
- COMPLETED
- Phase
- PHASE2
Tissue Banking Study - Polycythemia Vera or Essential Thrombocythemia (PV & ET) Patients
- Status
- COMPLETED
- Phase
- N/A
Pegylated Interferon Alpha-2b Versus Hydroxyurea in Polycythemia Vera
- Status
- COMPLETED
- Phase
- PHASE3
A Two-part Study to Assess the Safety and Preliminary Efficacy of Givinostat in Patients With Polycythemia Vera
- Status
- COMPLETED
- Phase
- PHASE1/PHASE2
Myeloproliferative Neoplasms: an In-depth Case-control Study
- Status
- COMPLETED
- Phase
- N/A
Myeloproliferative Neoplasms and Bone Structure
- Status
- UNKNOWN
- Phase
- N/A
A Phase Ib/II Dose-finding Study to Assess the Safety and Efficacy of LDE225 + INC424 in Patients With MF
- Status
- COMPLETED
- Phase
- PHASE1/PHASE2
Reduced-Intensity Conditioning Before Donor Stem Cell Transplant in With High-Risk Hematologic Malignancies
- Status
- COMPLETED
- Phase
- PHASE2
Large-scale Trial Testing the Intensity of CYTOreductive Therapy in Polycythemia Vera (PV)
- Status
- TERMINATED
- Phase
- PHASE3
Randomized Switch Study From Hydroxyurea to Ruxolitinib for RELIEF of Polycythemia Vera Symptoms: The Relief Study
- Status
- COMPLETED
- Phase
- PHASE3
Vaccine Therapy in Preventing Cytomegalovirus Infection in Patients With Hematological Malignancies Undergoing Donor Stem Cell Transplant
- Status
- COMPLETED
- Phase
- PHASE1
Fludarabine Phosphate, Melphalan, and Low-Dose Total-Body Irradiation Followed by Donor Peripheral Blood Stem Cell Transplant in Treating Patients With Hematologic Malignancies
- Status
- COMPLETED
- Phase
- PHASE2
Study of LY2784544 Testing Alternative Dosing in Participants With Myeloproliferative Neoplasms
- Status
- COMPLETED
- Phase
- PHASE1
Fludarabine Based Conditioning for Allogeneic Transplantation for Advanced Hematologic Malignancies
- Status
- COMPLETED
- Phase
- NA
A Study of Low Dose Interferon Alpha Versus Hydroxyurea in Treatment of Chronic Myeloid Neoplasms
- Status
- COMPLETED
- Phase
- PHASE3
A Two-Step Approach to Reduced Intensity Bone Marrow Transplant for Patients With Hematological Malignancies
- Status
- COMPLETED
- Phase
- PHASE2
Natural Killer Cells and Polycythemia Vera (Vaquez's Disease)
- Status
- UNKNOWN
- Phase
- N/A
Study of Efficacy and Safety in Polycythemia Vera Subjects Who Are Resistant to or Intolerant of Hydroxyurea: JAK Inhibitor INC424 (INCB018424) Tablets Versus Best Available Care: (The RESPONSE Trial)
- Status
- COMPLETED
- Phase
- PHASE3